×
Do you want to link to this External Site and leave Amgenbd.com?
You will be redirected in 5 seconds.
No, Return to Amgenbd.com
Yes, Leave Amgenbd.com
YOU ARE NOW LEAVING THE AMGENBD WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Our Process

Amgen actively seeks innovations within other companies and universities that will enhance our capabilities and augment our therapeutic offerings. Although our scientists and business specialists are in constant contact with their peers, we encourage researchers to contact us with potential opportunities. We strive to ensure that your opportunity receives a prompt yet comprehensive evaluation.

Our process involves three key steps. First, our team conducts an initial evaluation of the non-confidential data you provide. Next, an integrated evaluation team examines confidential data in detail. This team may include members of your staff as well as Amgen representatives from research, manufacturing, preclinical and clinical development, sales and marketing, senior management, law, and corporate development, as appropriate. Finally, Amgen Business Development leads due diligence efforts, along with the negotiation of deal terms.

Flexible and Innovative Deal Structuring

Recent transactions include spinouts, equity investments, joint ventures, early-stage partnerships, limited partnership investments, collaborations, in- and out-licensing, and acquisitions.

Deal Success Stories